1Thiedemann K U,Ferrans V J.Left atrial ultrastructure in mitral valvular disease[J].Am J Pathol,1977,89(3):575-604.
2Morillo C A,Klein G J,Jones D L,et al.Chronic rapid atrial pacing.Structural,functional,and electrophysiological characteristics of a new model of sustained atrial fibrillation[J].Circulation,1995,91(5):1588-1595.
3Ausma J,Wijffels M,Thone F,et al.Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat[J].Circulation,1997,96(9):3157-3163.
7Kanagaratnam P,Cherian A,Stanbridge R D,et al.Relationship between connexins and atrial activation during human atrial fibrillation[J].J Cardiovasc Electrophysiol,2004,15(2):206-216.
8Boldt A,Wetzel U,Weigl J,et al.Expression of angiotensin Ⅱ receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease[J].J Am Coll Cardiol,2003,42(10):1785-1792.
9Ausma J,Wijffels M,Van Eys G,et al.Dedifferentiation of atrial eardiomyocytes as a result of chronic atrial fibrillation[J].Am J Pathol,1997,151(4):985-997.
10Brundel B J,Ausma J,Van Gelder I C,et al.Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation[J].Cardiovase Res,2002,54(2):380-389.
二级参考文献23
1Van Wagoner DR, Nerbonne JM. Molecular basis of electrical remodeling in atrial fibrillation [J]. J Mol Cell Cardiol, 2000, 32:1101.
2Saffitz JE, Davis LM, Darrow B J, et al. The molecular basis of anisotropy: role of gap junctions [J]. J Cardiovasc Electrophysiol, 1995, 6:498.
3Sharp WW, Tettacio L, Borg TK, et al. Contractile activity modulates act.in synthesis and turnover in cultured neonatal rat [J]. Cir Res, 1993, 73:172.
4Sempe AC, Folliguet T, Martin RC, et al. Myoeadial cell death in fibrillation and dilated human right atrial[J]. J Am Coll Cardiol, 1999, 34:1577.
5Brodsky MA, Allen B J, Capparelli EV, et al. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation [J]. Am J Cardiol, 1989,63:1065.
6Ohkusa T, Ueyama T, Yamada J, et al. Alterations in cardiac sarcoplasmic reticulum Ca^2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation [J]. J Am Coll Cardiol, 1999, 34:255.
7Goette A, Honeycutt C, Langberg JL. Electrical remodeling in atrial fibrillation: time cause and mechanisms[J]. Circulation, 1996, 94:2968.
8Ausma J, Wijffels, M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat [J]. Circulation, 1997, 96:3157.
9White CW, Kerber RE, Weiss HR, et al. The effects of atrial fibrillation on atrial pressure-volume and flow relationships [J]. Circ Res, 1982, 51:205.
10Thomas H, Li H, Mangrum M,et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation[J]. Circulatin, 2000, 102:1 454.
3CAVALLERO S, GONZALEZ G E, SEROPIAN I M, et al. Ventricular function and natriuretic peptidesin sequentially combined models of hypertension[J]. Am J Physiol Heart Circ Physiol, 2010, 298(4): 1 290-1 299.
4SEVER P S, DAHLOF B vention of coronary and POULTER N R, et al. Pre- stroke events with ator- vastatin in hypertensive patients who have aver-age or lower-than-average cholesterol comcentra- tions, in the anglo-scandinavian cardiac outcomes trial-ipid lowering arm (ASCOT-LLA): a multicen- tre randomised controlled trial[J]. Lancet, 2003, 361(9364): 1 149-1158.
5BANACH M, MIKHAILIDIS D P, KJELDSEN S E, et al. Time for new indications for statins[J]. Med Sci Monit, 2009, 15(12): 1-5.
6ZHANG Ai-lian, Wu Shi-yao. Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced my- ocarditis[J]. Inflamm Res, 2010, 59(4): 255-262.
7PATTI G, CHELLO M, CANDURA D, et al. Random- ized trial of atorvastatin for reduction of postopera- tive atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (atorvastatin for reduction of myocardial dysrhythmia after cardiacsurgery) study[J]. Circulation, 2006, 114(14): 1455- 1 461.
8CAO H, XUE L, Wu Y, et al. Natriuretic peptides and right atrial fibrosis in patients with paroxys- mal versus persistent atrial fibrillation[J]. Peptides, 2010, 31(8): 1 531-1539.
9TAKAHASHI Y, SATOH M, MINAMI Y, et al. Expres- sion of miR-146a/b is associated with the toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and toll-like receptor 4 levels[J]. Clin Sci, 2010, 119(9): 395-405.
10PELLIEUX C, MONTESSUIT C, PAPAGEORGIOU I, et al. Angiotensin II downregulates the fatty acid oxi-dation pathway in adult rat cardiomyocytes via re- lease of tumour necrosis factor-alpha[J]. Cardiovasc Res, 2009, 82(2): 341-350.
